Group 1 - The company announced that its director and deputy general manager, Zhou Huoliang, plans to reduce his shareholding by up to 1.9625 million shares, which represents no more than 0.29% of the company's total share capital [1] - The share reduction will be conducted through centralized bidding within three months after the announcement, starting from 15 trading days post-disclosure [1] - The reduction price will be determined based on market conditions, indicating potential variability in the execution of the plan [1]

浙江吉华集团股份有限公司 浙江吉华集团股份有限公司(以下简称"公司")于 2025 年 4 月 28 日召开 的第五届董事会第六次会议和第五届监事会第五次会议审议通过了《关于使用 部分闲置募集资金临时补充流动资金的议案》，同意公司使用 2 亿元闲置募集 资金临时补充公司流动资金，使用期限为 12 个月（自董事会审议通过之日起计 算）。具体内容详见公司于 2025 年 4 月 29 日在《上海证券报》《证券时报》 及上海证券交易所网站（www.sse.com.cn)披露的《吉华集团关于使用部分闲置 募集资金临时补充流动资金的公告》（公告编号：2025-024）。 证券代码：603980 证券简称：吉华集团 公告编号：2025-049 关于使用部分闲置募集资金临时补充流动资金提前归还的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 特此公告。 浙江吉华集团股份有限公司 董事会 2025年7月29日 截至本公告披露日，公司已将临时补流资金 53,000,000.00 元归还至募集 资金专户，并将上述情况通知了公司保荐机构 ...

中国经济网北京7月22日讯吉华集团（603980）(603980.SH)今日收报5.62元，跌幅4.10%，总市值38.04 亿元。目前该股处于破发状态。 吉华集团于2017年6月15日在上交所主板上市，发行数量为10,000万股，发行价格为17.20元/股，保荐机 构(主承销商)为安信证券股份有限公司(现为"国投证券股份有限公司")，保荐代表人为袁弢、湛瑞锋。 吉华集团首次公开发行募集资金总额172,000.00万元，扣除发行费用后，募集资金净额为163,248.24万 元，分别用于"年产11250吨高性能分散染料、7500吨高溶解性高强度酸性系列染料、11250吨高溶解性 高强度直接系列染料、10000吨活性系列染料项目""年产3000吨1-氨基蒽醌技术改造项目""年产2万吨H- 酸(二期)生产线技改项目""年产3万吨活性染料扩能技术改造项目""补充营运资金"。 吉华集团发行费用总额为8,751.76万元，其中承销保荐费7,795.57万元。 2018年年度权益分派实施公告显示，本次利润分配及转增股本以方案实施前的公司总股本500,000,000股 为基数，每股派发现金红利0.45元(含税)，以资本公积金 ...

Group 1 - The Alzheimer's concept sector increased by 2.28%, ranking fifth among concept sectors, with 27 stocks rising, including Wanbangde, Lisheng Pharmaceutical, and Zhejiang Zhenyuan reaching the daily limit [1] - Notable gainers in the sector included Jihua Group, Xinhua Pharmaceutical, and Boji Pharmaceutical, which rose by 5.85%, 4.98%, and 4.93% respectively [1] - The sector experienced a net inflow of 498 million yuan from main funds, with 21 stocks receiving net inflows, and six stocks seeing inflows exceeding 50 million yuan [2] Group 2 - The top stock in terms of net inflow was Huahai Pharmaceutical, with a net inflow of 87.51 million yuan, followed by Boji Pharmaceutical, Jihua Group, and Haizheng Pharmaceutical with inflows of 55.18 million yuan, 54.13 million yuan, and 53.91 million yuan respectively [2][3] - Zhejiang Zhenyuan and Boji Pharmaceutical had the highest net inflow ratios at 29.25% and 16.16% respectively [3] - The overall performance of the Alzheimer's concept sector was supported by significant trading volumes, with stocks like Lisheng Pharmaceutical and Wanbangde showing substantial price increases of 10% [4]

本次交易已经公司第五届董事会第八次会议审议通过，具体内容及进 展情况详见公司于2025年5月14日、5月27日、5月31日及6月13日在指定媒 体披露的《吉华集团关于子公司对外出售部分资产的公告》（公告编号 告 编 号 2025-040 ） 、 《 吉 华 集 团 关 于 子 公 司 对 外 出 售 部 分 资 产 的 进 展 公 告》（公告编号2025-041 ）及《吉华集团关于子公司对外出售部分资产的 进展公告》（公告编号2025-044）。 重要内容提示： ?浙江吉华集团股份有限公司全资子公司江苏吉华化工有限公司向滨海 县 沿 海投 资发展有 限 公司出 售登 记在《苏2018 滨海县不 动产权第0000604 号》上的300,030.60平方米土地使用权和30,182.06平方米房屋所有权，以 及在上述土地上的其他建筑物、构筑物及附属设施。本次交易总金额为 证券代码：603980 证券简称：吉华集团 公告编号：2025-048 ?近日，江苏吉华化工有限公司收到资产转让款500.00万元。截至本 公告披露日，累计收到资产转让款8,500.00万元，本次交易完成。 浙江吉华集团股份有限公司 一、交易概述 ...

证券代码：603980 证券简称：吉华集团 公告编号：2025-048 浙江吉华集团股份有限公司全资子公司江苏吉华化工有限公司向滨海 县沿海投资发展有限公司出售登记在《苏2018滨海县不动产权第0000604 号》上的300,030.60平方米土地使用权和30,182.06平方米房屋所有权，以 及在上述土地上的其他建筑物、构筑物及附属设施。本次交易总金额为 8,500.00万元。 近日，江苏吉华化工有限公司收到资产转让款500.00万元。截至本 公告披露日，累计收到资产转让款8,500.00万元，本次交易完成。 浙江吉华集团股份有限公司 一、交易概述 关于子公司对外出售部分资产的进展公告 为盘活闲置资产，提高资产运营效率，降低运营成本，同时响应滨海 县沿海工业园区（以下简称"园区"）关于所在港口片区整体开发的战略 部署，为园区重大产业项目落地实施提供要素保障。 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示： 本次交易已经公司第五届董事会第八次会议审议通过，具体内容及进 展情况详见公司于2025年5月14日 ...

Group 1 - The A-share silicon-based materials sector experienced a pullback during trading, with significant declines in several companies [1] - Hongbai New Materials hit the daily limit down, indicating a strong negative market reaction [1] - Other companies such as Feilu Co., Jitai Co., Chenguang New Materials, and Jihua Group also saw declines, following the trend set by Hongbai New Materials [1]

[Current Period Performance Forecast Details](index=1&type=section&id=Item%201.%20Current%20Period%20Performance%20Forecast) The company anticipates a significant 95.60% year-over-year decrease in net profit attributable to shareholders for H1 2025 to 4.4 million yuan, while net profit attributable to shareholders excluding non-recurring gains/losses is expected to narrow its loss to -9.8 million yuan, a 24.71% year-over-year improvement; this forecast is unaudited Key Performance Indicators Forecast | Indicator | 2025 H1 Forecast | 2024 H1 | YoY Change | | :--- | :--- | :--- | :--- | | Net Profit Attributable to Parent Company Shareholders | 4.40 million yuan | 100.07 million yuan | -95.60% | | Net Profit Attributable to Parent Company Shareholders Excluding Non-Recurring Gains/Losses | -9.80 million yuan | -13.02 million yuan | +24.71% | - The performance forecast data has not been audited by a certified public accountant[4](index=4&type=chunk) [Prior Period Performance Review](index=1&type=section&id=Item%202.%20Prior%20Period%20Operating%20Performance%20and%20Financial%20Position) In the same period of 2024, the company achieved a net profit attributable to parent company shareholders of 100.07 million yuan, but a net loss attributable to parent company shareholders excluding non-recurring gains/losses of 13.02 million yuan, indicating that prior period profit was primarily driven by non-recurring items 2024 H1 Key Financial Data | Indicator | 2024 H1 Data | | :--- | :--- | | Total Profit | 141.07 million yuan | | Net Profit Attributable to Parent Company Shareholders | 100.07 million yuan | | Net Profit Attributable to Parent Company Shareholders Excluding Non-Recurring Gains/Losses | -13.02 million yuan | | Earnings Per Share | 0.14 yuan | [Analysis of Performance Change](index=2&type=section&id=Item%203.%20Primary%20Reasons%20for%20Current%20Period%20Performance%20Decline) The significant decline in net profit attributable to parent company shareholders is primarily due to a 159.39 million yuan asset disposal gain in the prior period, leading to an 87.44% year-over-year decrease in current period net non-recurring gains/losses, which explains the improved non-recurring adjusted net profit despite the overall decline - Current period net non-recurring gains/losses are approximately **14.20 million yuan**, a significant **87.44% year-over-year decrease**[7](index=7&type=chunk) - The performance change is mainly due to a **159.39 million yuan** asset disposal gain recognized by the company's wholly-owned subsidiary in the prior period due to government demolition requirements, which did not recur in the current period[7](index=7&type=chunk) [Risk Warning](index=2&type=section&id=Item%204.%20Risk%20Warning) The company emphasizes that this performance forecast is unaudited and currently there are no other significant uncertainties affecting the accuracy of the forecast content - The company's estimated performance has not been audited by the annual certified public accountant, and the company confirms there are no significant uncertainties affecting the accuracy of this performance forecast[8](index=8&type=chunk) [Other Explanatory Notes](index=2&type=section&id=Item%205.%20Other%20Explanatory%20Notes) The company reminds investors that the disclosed data is preliminary, and the final accurate financial data will be based on the officially released 2025 semi-annual report; investors are advised to be aware of investment risks - The above forecast data is only preliminary, and the specific accurate financial data will be subject to the company's officially disclosed 2025 semi-annual report[9](index=9&type=chunk)

Core Viewpoint - The price of H acid has significantly increased, leading dye companies to cautiously manage their production capacity [1] Company Summaries - Jinji Co. has not yet started trial production of its 8000 tons capacity for H acid [1] - Runtou Co. and Jihua Group have their H acid facilities currently in a state of suspension [1] - Zhejiang Longsheng has some facilities in trial production [1] Industry Insights - Recent data indicates that H acid prices have surpassed 44,000 yuan per ton, reflecting an increase of 8,000 yuan per ton since the beginning of the year [1]

证券代码：603980 证券简称：吉华集团 公告编号：2025-046 风险提示：公司购买的"中建投信托·安泉593号（青岛融创）集合 资金信托计划"存在延期兑付风险。鉴于此次投资款项的收回尚存在不确 定性，并基于非保本理财产品的性质，故存在本金无法全额收回的风险。 一、信托延期兑付情况： （一）信托计划名称：中建投信托·安泉593号（青岛融创）集合资金 信托计划 关于中建投信托产品逾期兑付事项进展公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示： 信托产品名称：中建投信托·安泉593号（青岛融创）集合资金信托 计划（以下简称"本信托计划"） 受托方：中建投信托股份有限公司（以下简称"中建投信托"） 购买金额：5,000万元（公司自有资金） 浙江吉华集团股份有限公司 （四）清算期限：2023年2月9日起，至信托财产全部变现并完成向受 益人分配之日止 公司将继续积极联系各相关方，尽最大努力保障公司利益。督促中建投信 托密切追踪融资人及项目情况，尽快向公司兑付余下的投资本息。 （二）理财金额：5,000万元 ...